Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Nov;116(5):2441–2446. doi: 10.1111/j.1476-5381.1995.tb15093.x

Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells.

J C Yu 1, J D Pickard 1, A P Davenport 1
PMCID: PMC1909054  PMID: 8581282

Abstract

1. Endothelin (ET) has been implicated in cerebrovasospasm for example, following subarachnoid haemorrhage, and blocking the interaction of ET with its receptors on cerebral vessels, may be of therapeutic benefit. The aim of our study was to characterize endothelin receptor sub-types on medial smooth muscle cells of human cerebral vessels. Cultures of vascular smooth muscle cells were explanted from human cerebral resistance vessels and characterized as human brain smooth muscle cells (HBSMCs). 2. Over a 48 h incubation period, HBSMC cultures secreted comparable levels of immunoreactive (IR) big endothelin-1 (big ET-1) and IR endothelin (ET): 12.7 +/- 10.3 and 8.3 +/- 5.6 pmol/10(6) cells, respectively (mean +/- s.e. mean from three different individuals), into the culture medium. 3. Total RNA was extracted from cultures of human brain smooth muscle cells. Reverse-transcriptase polymerase chain reaction (RI-PCR) assays and subsequent product separation by agarose gel electrophoresis revealed single bands corresponding to the expected product sizes encoding cDNA for ETA (299 base pairs) and ETB (428 base pairs) (n = 3 different cultures). 4. Autoradiography demonstrated the presence of specific binding sites for [125I]-ET-1 which labels all ET receptors, and [125I]-PD151242, an ETA subtype-selective antagonist which exclusively labels ETA receptors, but no specific-binding was detected using ETB subtype-selective [125I]-BQ3020 (n = 3 different cultures, in duplicate). 5. In saturation binding assays, [123I]-ET-1 bound with high affinity: KD = 0.8 +/- 0.1 nM and Bmax = 690 +/- 108 fmol mg-1. A one-site fit was preferred and Hill slopes were close to unity over the concentration range (10(-12) to 10(-8) M). [125I]-PD151242 also bound with similar affinity: KD = 0.4 +/- 0.1 nM and Bmax = 388 +/- 68 fmol mg-1 (mean +/- s.e. mean, n = 3 different cultures). Again, a one-site fit was preferred and Hill slopes were close to unity over the concentration range. Unlabelled PD151242 competed for the binding of [125I]-ET-1 monophasically and analysis of the competition curves indicated that a one-site fit was preferred over a two-site model, implying that the cultures express mainly ETA receptors. 6. Although messenger RNA encoding both ETA and ETB receptors was detected, autoradiographical analysis, as well as binding studies indicate that human cultured brain smooth muscle cells express only ETA receptor protein. Antagonism of this sub-type may be necessary to block the actions of ET-1 in the human cerebral resistance vessels in the vasospasm observed subsequent to subarachnoid haemorrhage.

Full text

PDF
2446

Images in this article

2443Figure 1
on p.2443
2444Figure 2
on p.2444

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990 Dec 20;348(6303):730–732. doi: 10.1038/348730a0. [DOI] [PubMed] [Google Scholar]
  2. Bacic F., Uematsu S., McCarron R. M., Spatz M. Secretion of immunoreactive endothelin-1 by capillary and microvascular endothelium of human brain. Neurochem Res. 1992 Jul;17(7):699–702. doi: 10.1007/BF00968008. [DOI] [PubMed] [Google Scholar]
  3. Bian L. G., Zhang T. X., Zhao W. G., Shen J. K., Yang G. Y. Increased endothelin-1 in the rabbit model of middle cerebral artery occlusion. Neurosci Lett. 1994 Jun 6;174(1):47–50. doi: 10.1016/0304-3940(94)90115-5. [DOI] [PubMed] [Google Scholar]
  4. Boulanger C., Lüscher T. F. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990 Feb;85(2):587–590. doi: 10.1172/JCI114477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  6. Clozel M., Breu V., Burri K., Cassal J. M., Fischli W., Gray G. A., Hirth G., Löffler B. M., Müller M., Neidhart W. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993 Oct 21;365(6448):759–761. doi: 10.1038/365759a0. [DOI] [PubMed] [Google Scholar]
  7. Clozel M., Watanabe H. BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci. 1993;52(9):825–834. doi: 10.1016/0024-3205(93)90081-d. [DOI] [PubMed] [Google Scholar]
  8. Davenport A. P., O'Reilly G., Kuc R. E. Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type. Br J Pharmacol. 1995 Mar;114(6):1110–1116. doi: 10.1111/j.1476-5381.1995.tb13322.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Davenport A. P., O'Reilly G., Molenaar P., Maguire J. J., Kuc R. E., Sharkey A., Bacon C. R., Ferro A. Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle. J Cardiovasc Pharmacol. 1993;22 (Suppl 8):S22–S25. doi: 10.1097/00005344-199322008-00008. [DOI] [PubMed] [Google Scholar]
  10. Edvinsson L., Juul R., Jansen I. Perivascular neuropeptides (NPY, VIP, CGRP and SP) in human brain vessels after subarachnoid haemorrhage. Acta Neurol Scand. 1994 Nov;90(5):324–330. doi: 10.1111/j.1600-0404.1994.tb02732.x. [DOI] [PubMed] [Google Scholar]
  11. Ehrenreich H., Lange M., Near K. A., Anneser F., Schoeller L. A., Schmid R., Winkler P. A., Kehrl J. H., Schmiedek P., Goebel F. D. Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhage. Res Exp Med (Berl) 1992;192(4):257–268. doi: 10.1007/BF02576282. [DOI] [PubMed] [Google Scholar]
  12. Godfraind T. Endothelin receptors in human coronary arteries. Trends Pharmacol Sci. 1994 May;15(5):136–137. doi: 10.1016/0165-6147(94)90068-x. [DOI] [PubMed] [Google Scholar]
  13. Itoh S., Sasaki T., Asai A., Kuchino Y. Prevention of delayed vasospasm by an endothelin ETA receptor antagonist, BQ-123: change of ETA receptor mRNA expression in a canine subarachnoid hemorrhage model. J Neurosurg. 1994 Nov;81(5):759–764. doi: 10.3171/jns.1994.81.5.0759. [DOI] [PubMed] [Google Scholar]
  14. Itoh S., Sasaki T., Ide K., Ishikawa K., Nishikibe M., Yano M. A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem Biophys Res Commun. 1993 Sep 15;195(2):969–975. doi: 10.1006/bbrc.1993.2139. [DOI] [PubMed] [Google Scholar]
  15. Kasuya H., Weir B. K., White D. M., Stefansson K. Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells. J Neurosurg. 1993 Dec;79(6):892–898. doi: 10.3171/jns.1993.79.6.0892. [DOI] [PubMed] [Google Scholar]
  16. Kobayashi H., Hayashi M., Kobayashi S., Kabuto M., Handa Y., Kawano H. Effect of endothelin on the canine basilar artery. Neurosurgery. 1990 Sep;27(3):357–361. doi: 10.1097/00006123-199009000-00003. [DOI] [PubMed] [Google Scholar]
  17. Levesque H., Sevrain L., Freger P., Tadie M., Courtois H., Creissard P. Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet. 1990 Feb 3;335(8684):290–290. doi: 10.1016/0140-6736(90)90106-f. [DOI] [PubMed] [Google Scholar]
  18. Macdonald R. L., Weir B. K. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991 Aug;22(8):971–982. doi: 10.1161/01.str.22.8.971. [DOI] [PubMed] [Google Scholar]
  19. Maguire J. J., Kuc R. E., O'Reilly G., Davenport A. P. Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br J Pharmacol. 1994 Sep;113(1):49–54. doi: 10.1111/j.1476-5381.1994.tb16172.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Masaoka H., Suzuki R., Hirata Y., Emori T., Marumo F., Hirakawa K. Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet. 1989 Dec 9;2(8676):1402–1402. doi: 10.1016/s0140-6736(89)92019-9. [DOI] [PubMed] [Google Scholar]
  21. McPherson G. A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed. 1983 Aug-Oct;17(1-2):107–113. doi: 10.1016/0010-468x(83)90031-4. [DOI] [PubMed] [Google Scholar]
  22. Molenaar P., Kuc R. E., Davenport A. P. Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart. Br J Pharmacol. 1992 Nov;107(3):637–639. doi: 10.1111/j.1476-5381.1992.tb14498.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  24. Nirei H., Hamada K., Shoubo M., Sogabe K., Notsu Y., Ono T. An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sci. 1993;52(23):1869–1874. doi: 10.1016/0024-3205(93)90007-p. [DOI] [PubMed] [Google Scholar]
  25. O'Reilly G., Charnock-Jones D. S., Davenport A. P., Cameron I. T., Smith S. K. Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle. J Clin Endocrinol Metab. 1992 Dec;75(6):1545–1549. doi: 10.1210/jcem.75.6.1464662. [DOI] [PubMed] [Google Scholar]
  26. Ohlstein E. H., Storer B. L. Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg. 1992 Aug;77(2):274–278. doi: 10.3171/jns.1992.77.2.0274. [DOI] [PubMed] [Google Scholar]
  27. Papadopoulos S. M., Gilbert L. L., Webb R. C., D'Amato C. J. Characterization of contractile responses to endothelin in human cerebral arteries: implications for cerebral vasospasm. Neurosurgery. 1990 May;26(5):810–815. doi: 10.1097/00006123-199005000-00013. [DOI] [PubMed] [Google Scholar]
  28. Peter M. G., Davenport A. P. Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart. Br J Pharmacol. 1995 Jan;114(2):297–302. doi: 10.1111/j.1476-5381.1995.tb13226.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rosenblum W. I. Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide. Stroke. 1992 Oct;23(10):1527–1532. doi: 10.1161/01.str.23.10.1527. [DOI] [PubMed] [Google Scholar]
  30. Sagher O., Jin Y., Thai Q. A., Fergus A., Kassell N. F., Lee K. S. Cerebral microvascular responses to endothelins: the role of ETA receptors. Brain Res. 1994 Sep 26;658(1-2):179–184. doi: 10.1016/s0006-8993(09)90024-5. [DOI] [PubMed] [Google Scholar]
  31. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990 Dec 20;348(6303):732–735. doi: 10.1038/348732a0. [DOI] [PubMed] [Google Scholar]
  32. Seifert V., Löffler B. M., Zimmermann M., Roux S., Stolke D. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg. 1995 Jan;82(1):55–62. doi: 10.3171/jns.1995.82.1.0055. [DOI] [PubMed] [Google Scholar]
  33. Shyamala V., Moulthrop T. H., Stratton-Thomas J., Tekamp-Olson P. Two distinct human endothelin B receptors generated by alternative splicing from a single gene. Cell Mol Biol Res. 1994;40(4):285–296. [PubMed] [Google Scholar]
  34. Spatz M., Stanimirovic D., Bacic F., Uematsu S., McCarron R. M. Vasoconstrictive peptides induce endothelin-1 and prostanoids in human cerebromicrovascular endothelium. Am J Physiol. 1994 Mar;266(3 Pt 1):C654–C660. doi: 10.1152/ajpcell.1994.266.3.C654. [DOI] [PubMed] [Google Scholar]
  35. Stanimirovic D. B., McCarron R., Bertrand N., Spatz M. Endothelins release 51Cr from cultured human cerebromicrovascular endothelium. Biochem Biophys Res Commun. 1993 Feb 26;191(1):1–8. doi: 10.1006/bbrc.1993.1176. [DOI] [PubMed] [Google Scholar]
  36. Stanimirovic D. B., Yamamoto T., Uematsu S., Spatz M. Endothelin-1 receptor binding and cellular signal transduction in cultured human brain endothelial cells. J Neurochem. 1994 Feb;62(2):592–601. doi: 10.1046/j.1471-4159.1994.62020592.x. [DOI] [PubMed] [Google Scholar]
  37. Suzuki H., Sato S., Suzuki Y., Takekoshi K., Ishihara N., Shimoda S. Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol Scand. 1990 Jun;81(6):553–554. doi: 10.1111/j.1600-0404.1990.tb01018.x. [DOI] [PubMed] [Google Scholar]
  38. Viossat I., Duverger D., Chapelat M., Pirotzky E., Chabrier P. E., Braquet P. Elevated tissue endothelin content during focal cerebral ischemia in the rat. J Cardiovasc Pharmacol. 1993;22 (Suppl 8):S306–S309. doi: 10.1097/00005344-199322008-00080. [DOI] [PubMed] [Google Scholar]
  39. Wei E. P., Moskowitz M. A., Boccalini P., Kontos H. A. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ Res. 1992 Jun;70(6):1313–1319. doi: 10.1161/01.res.70.6.1313. [DOI] [PubMed] [Google Scholar]
  40. Yamashita K., Kataoka Y., Niwa M., Shigematsu K., Himeno A., Koizumi S., Taniyama K. Increased production of endothelins in the hippocampus of stroke-prone spontaneously hypertensive rats following transient forebrain ischemia: histochemical evidence. Cell Mol Neurobiol. 1993 Feb;13(1):15–23. doi: 10.1007/BF00712986. [DOI] [PubMed] [Google Scholar]
  41. Yoshimoto S., Ishizaki Y., Kurihara H., Sasaki T., Yoshizumi M., Yanagisawa M., Yazaki Y., Masaki T., Takakura K., Murota S. Cerebral microvessel endothelium is producing endothelin. Brain Res. 1990 Feb 5;508(2):283–285. doi: 10.1016/0006-8993(90)90407-3. [DOI] [PubMed] [Google Scholar]
  42. Yu J. C., Davenport A. P. Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br J Pharmacol. 1995 Jan;114(2):551–557. doi: 10.1111/j.1476-5381.1995.tb13262.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Zhang W. W., Badonic T., Hög A., Jiang M. H., Ma K. C., Nie J. X., Olsson Y., Sourander P. Structural and vasoactive factors influencing intracerebral arterioles in cases of vascular dementia and other cerebrovascular disease: a review. Immunohistochemical studies on expression of collagens, basal lamina components and endothelin-1. Dementia. 1994 May-Aug;5(3-4):153–162. doi: 10.1159/000106714. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES